股票行情快报：五洲医疗（301234）2月9日主力资金净买入76.27万元

Group 1 - The core viewpoint of the news is that Wuzhou Medical (301234) has shown a slight increase in stock price, with a closing price of 41.9 yuan on February 9, 2026, reflecting a 1.4% rise [1] - The company reported a main revenue of 345 million yuan for the first three quarters of 2025, representing a year-on-year increase of 0.82% [2] - The net profit attributable to the parent company for the same period was 18.51 million yuan, showing a significant year-on-year decline of 46.09% [2] Group 2 - In the third quarter of 2025, the company's single-quarter main revenue was 128 million yuan, which is a year-on-year decrease of 1.51% [2] - The net profit attributable to the parent company for the third quarter was 7.99 million yuan, down 36.39% year-on-year [2] - The company's debt ratio stands at 12.32%, with an investment income of 3.67 million yuan and a financial expense of -2.07 million yuan [2] Group 3 - The company operates in the field of research, production, and sales of disposable sterile infusion medical devices, primarily using an "ODM + integrated supply" model to meet the one-stop procurement needs of foreign medical device brand owners [2] - The gross profit margin for the company is reported at 14.22% [2] Group 4 - On February 9, 2026, the net inflow of main funds was 762,700 yuan, accounting for 2.21% of the total transaction amount [1] - Retail investors saw a net inflow of 1.40 million yuan, representing 4.06% of the total transaction amount, while speculative funds experienced a net outflow of 2.17 million yuan, which is 6.27% of the total transaction amount [1]